ST. LOUIS, Feb. 21, 2023 (WORLD WIRE SERVICE)– Stereotaxis STXS, a leader as well as international leader in medical robotics for minimally intrusive endovascular treatment, today revealed that David Fischel, Chairman as well as chief executive officer, will certainly take part in the Cowen 43 rd Yearly Healthcare Meeting.
Mr. Fischel will certainly offer on Stereotaxis’ organization as well as modern technology throughout a Fireplace Conversation with Josh Jennings, Cowen’s Handling Supervisor & & Elder Study Expert, on Monday, March 6, 2023, at 11:10 am ET. Mr. Fischel will certainly be readily available for individually conferences the rest of the day.
” We expect signing up with Cowen as well as sharing Stereotaxis’ distinguished modern technology, medical worth, as well as development method with capitalists,” states Mr. Fischel.
Regarding Stereotaxis
Stereotaxis STXS is a leader as well as international leader in ingenious medical robotics for minimally intrusive endovascular treatment. Its goal is the exploration, advancement as well as distribution of robot systems, tools, as well as info services for the interventional research laboratory. These advancements assist medical professionals give unparalleled individual treatment with robot accuracy as well as security, broaden accessibility to minimally intrusive treatment, as well as boost the performance, connection, as well as knowledge in the operating area. Stereotaxis modern technology has actually been utilized to deal with over 100,000 individuals throughout the USA, Europe, Asia, as well as in other places. For additional information, please browse through www.stereotaxis.com.
Capitalist Get In Touches With:
David L. Fischel
Chairman as well as Ceo
Kimberly Peery
Principal Financial Policeman
314-678-6100
[email protected]
